Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

Summary

Study to evaluate the efficacy, safety, tolerability and pharmacokinetics of JTE-051 administered for 12 weeks in subjects with moderate to severe plaque psoriasis.

Timeline

Start

2017-11-10

Primary completion

2018-10-29

Completion

2018-10-29

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulty faced with enrollment in the study”

Drugs

Indications